Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person15
L1 Capital Global Opportunities Master Fund, Ltd.
Company
Clough Global Opportunities Fund
Company
ATW OPPORTUNITIES MASTER FUND LP
Company
OneAscent Capital Opportunities Fund
Company
Soleus Capital Master Fund, L.P.
Company
Lord Abbett Municipal Opportunities Fund
Company
Avenue RP Opportunities Fund, L.P.
Company
KKR Income Opportunities Fund
Company
Nuveen Municipal Credit Opportunities Fund
Company
ALLSPRING GLOBAL DIVIDEND OPPORTUNITY FUND
Company
RIVERNORTH OPPORTUNITIES FUND, INC.
Company
DoubleLine Yield Opportunities Fund
Company
ALLSPRING INCOME OPPORTUNITIES FUND
Company
Macquarie Infrastructure Income Opportunities Fund
Company
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND
Company
Primary record15
INLIF Ltd filed SCHEDULE 13G
on October 20, 2026. David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L1 Capital Global Opportunities Master Fund, Ltd., Mr. Feldman, and Mr. Arber may be deeme
DarkIris Inc. filed SCHEDULE 13G
on October 9, 2026 and information provided by the Issuer. David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L1 Capital Global Opportunities Master Fund, Ltd., M
Baird Medical Investment Holdings Ltd filed SCHEDULE 13G
on September 24, 2026. David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L1 Capital Global Opportunities Master Fund, Ltd., Mr. Feldman, and Mr. Arber may be dee
L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G
on August 28, 2026. David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L1 Capital Global Opportunities Master Fund, Ltd., Mr. Feldman, and Mr. Arber may be deemed
L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G/A
on August 14, 2026. This amendment is being filed to correct a scrivener's error in such prior Schedule 13G/A which inadvertently reported 0 Class A Ordinary Shares as beneficially owned, and to instead reflect the Repor
L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G
on August 24, 2026. The numbers of shares outstanding gives no effect to any exercise of Pre-Funded Warrants or Common Warrants. David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fu
L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G
on August 20, 2026. The numbers of shares outstanding gives no effect to any exercise of Pre-Funded Warrants. David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L
Dare Bioscience, Inc. filed SCHEDULE 13G
on Form 8-K, each filed with the Securities and Exchange Commission on August 17, 2026. The numbers of shares outstanding gives no effect to any exercise of Pre-Funded Warrants. David Feldman and Joel Arber are the Direc
BNB PLUS CORP. filed SCHEDULE 13G/A
on May 15, 2026 covering 539,892 shares of common stock issuable upon exercise of Warrants purchased on May 28, 2024. The amounts in Row (5), (7) and (9) represent (i) 4,166 shares of common stock issuable upon exercise
C3is Inc. filed SCHEDULE 13G/A
on December 17, 2025, covering 443,213 Common Shares purchased on December 11, 2025. The amounts in Row (5), (7) and (9) represent 97,027 Series B-2 Warrants to purchase Common Shares, 112,617 Series C-2 Warrants to purc
Jiuzi Holdings, Inc. filed SCHEDULE 13G/A
on November 14, 2025, covering 4,000,000 Warrants to purchase Ordinary Shares purchased on September 30, 2025. The amounts in Row (5), (7) and (9) include 988,305 Warrants to purchase Ordinary Shares. The percentage set
L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G/A
on March 18, 2026 covering 175,442 Class A Ordinary Shares purchased on March 12, 2026. David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L1 Capital Global Oppor
L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G/A
on May 22, 2026 covering 1,000,000 Common Units purchased on May 18, 2026. The amounts in Row (5), (7) and (9) represent 5,344,378 Series B Warrants exercisable into shares of common stock and 400,000 Series C Warrants e
L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G/A
on June 23, 2026, covering 851,700 Common Stock purchased on June 16, 2026. The amounts in Row (5), (7) and (9) represent 608,824 Warrants, which is subject to a 9.99% beneficial ownership limitation. The percentage set
L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G/A
on June 5, 2026 covering 112,800 Class A Ordinary Shares purchased on June 3, 2026. David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L1 Capital Global Opportuni